Print

BrainStorm Cell Therapeutics Inc. Issues CEO Update to Shareholders  
3/29/2012 7:45:34 AM

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTCBB: BCLI), a developer of adult stem cell technologies and CNS therapeutics, has issued a CEO update to shareholders and investors, with a review of recent accomplishments.
//-->